We are live on ! Find out more
LPNT

LifePoint Health, Inc.
LPNT

Delisted

LPNT was delisted on the 15th of November, 2018.

219 hedge funds and large institutions have $2.12B invested in LifePoint Health, Inc. in 2018 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 82 increasing their positions, 74 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 27

11% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 74

7% more capital invested

Capital invested by funds: $1.98B → $2.12B (+$136M)

1% more funds holding

Funds holding: 217219 (+2)

53% less call options, than puts

Call options by funds: $1.05M | Put options by funds: $2.24M

Holders
219
Holders Change
+2
Holders Change %
+0.92%
% of All Funds
4.99%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
30
Increased
82
Reduced
74
Closed
27
Calls
$1.05M
Puts
$2.24M
Net Calls
-$1.19M
Net Calls Change
-$2.57M

LPNT Hedge Fund Activity: Q2 2018 in Review

219 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in LifePoint Health, Inc. (LPNT) for Q2 2018, worth a combined $2.12B — up 6.9% from $1.98B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new LPNT positions and 27 closed out — a net gain of 3 holders — while 82 added to existing stakes and 74 trimmed.

The largest buyer was BlackRock, adding an estimated $53.3M. The largest seller was OrbiMed, cutting an estimated $20.2M.

  • 219 institutional investors held LifePoint Health, Inc. (LPNT) as of Q2 2018, up from 217 in Q1 2018.
  • Funds reported $2.12B of LifePoint Health, Inc. stock for Q2 2018, up 6.9% quarter-over-quarter.
  • 30 funds opened new LifePoint Health, Inc. positions in Q2 2018 and 27 closed out, a net change of +3 holders.
  • The largest LifePoint Health, Inc. buyer in Q2 2018 was BlackRock, an estimated $53.3M added.
  • The largest LifePoint Health, Inc. seller in Q2 2018 was OrbiMed, an estimated $20.2M sold.

Based on aggregated 13F filings for Q2 2018.